Showing results (2661-2670 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|May 31, 2014
A phase I study of decitabine with pegylated interferon α-2b in advanced melanoma: impact on DNA methylation and lymphocyte populationsE R Plimack, J R Desai, J P Issa, et al.
Investigational New Drugs|August 16, 2012
Population pharmacokinetic modeling of sepantronium bromide (YM155), a small molecule survivin suppressant, in patients with non-small cell lung cancer, hormone refractory prostate cancer, or unresectable stage III or IV melanomaYumiko Aoyama, Atsunori Kaibara, Akitsugu Takada, et al.
Investigational New Drugs|June 13, 2014
First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumorsD S Hong, H Henary, G S Falchook, et al.
Investigational New Drugs|June 15, 2014
Novel antitumour indole alkaloid, Jerantinine A, evokes potent G2/M cell cycle arrest targeting microtubulesVijay J Raja, Kuan-Hon Lim, Chee-Onn Leong, et al.
Investigational New Drugs|May 10, 2023
Comparison of safety outcomes of anticancer drugs in Japanese and non-Japanese patients in multi-regional clinical trials: meta-analysis of safety profilesToshiyuki Tamai, Mamoru Narukawa
Investigational New Drugs|September 18, 1998
Phase II study of CI-980 (NSC 635370) in patients with previously treated advanced soft-tissue sarcomasS R Patel, M A Burgess, N E Papadopolous, et al.
Investigational New Drugs|January 24, 2015
Everolimus and pasireotide for advanced and metastatic hepatocellular carcinomaHanna K Sanoff, Richard Kim, Anastasia Ivanova, et al.
Investigational New Drugs|June 28, 2020
Mitomycin C plus cisplatin for systemic treatment of recurrent BRCA1-associated ovarian cancerTatyana V Gorodnova, Anna P Sokolenko, Sergey V Kondratiev, et al.
Investigational New Drugs|August 25, 2012
Phase II trial of single-agent foretinib (GSK1363089) in patients with recurrent or metastatic squamous cell carcinoma of the head and neckTanguy Seiwert, John Sarantopoulos, Howard Kallender, et al.
Investigational New Drugs|October 19, 2012
EGFR and HER2 inhibition in pancreatic cancerNaomi Walsh, Susan Kennedy, AnneMarie Larkin, et al.
Pageof 372